|
Biotechnology Parks and Incubators
The Biotechnology Parks and Biotech Incubation Centers
established under this programme provided a good template
for the promotion of Biotech startup companies and the
promotion of Public Private Partnerships. Biotech Park
and Incubation Centers have been established at
- Biotech Park at Lucknow,
Uttar Pradesh
- Biotechnology Incubation Centre, Hyderabad, Andhra
Pradesh
- Biotechnology Incubation Centre/ Pilot plant facilities
at Kerala
- Biotechnology Park/Incubation Centre and Common
instrumentation facility at Bangalore
- Biotechnology Incubation Centre/Pilot plant facilities
at Himachal Pradesh
Public Sector Undertaking
- Bharat Immunologicals and Biologicals Corporation
Limited,Bulandshahr
- Indian Vaccines Corporation Limited,Gurgaon
Autonomous Institutions
- National Institute of Immunology , New Delhi
- National Centre for Cell Science, Pune
- National Brain Research Centre, Manesar, Haryana
- Centre for DNA Fingerprinting and Diagnostics, Hyderabad
- National Institute of Plant Genome Research, New Delhi
- Institute of Life Sciences , Bhubaneswar
- Institute of Bioresources and Sustainable Development, Imphal
- Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram
- Institute of Stem Cell Biology and Regenerative Medicine, Bangalore
- Translational Health Sciences and Technology Institute, Faridabad
- National Institute of Biomedical Genomics, Kalyani, West Bengal
- Regional centre for Biotechnology, Faridabad
- National Agri-Food Biotechnology Institute, Mohali
- National Institute of Animal Biotechnology, Hyderabad
Policy Framework
National Biotechnolgy Development
Strategy
Biotechnology as a business segment
for India has the potential of generating revenues to
the tune of US$ 5 billion and creating one million jobs
by 2010 through products and services. This can propel
India into a significant position in the global biotech
sweepstakes. Biopharmaceuticals alone have the potential
to be a US$ 2 billion market opportunity largely driven
by vaccines and bio-generics.Clinical development services
can generate in excess of US$ 1.5 billion whilst bioservices
or outsourced research services can garner a market
of US$1 billion over this time scale. The balance US$500
million is attributable to agricultural and industrial
biotechnology.
India has many assets in its strong pool of scientist
and engineers, vast institutional network and cost effective
manufacturing. There are over a hundred National Research
Laboratories employing thousands of scientists. There
are more than 300 college level educational and training
institutes across the country offering degrees and diplomas
in biotechnology, bio-informatics and the biological
sciences, producing nearly 500,000 students on an annual
basis.More than 100 medical colleges add 17,000 medical
practitioners per year.About 300,000 postgraduates
and 1500 PhDs qualify in biosciences and engineering
each year. These resources need to be effectively marshaled,
championed and synergized to create a productive enterprise.
India is reorganized as a mega bio-diversity country
and biotechnology offers opportunities to convert our
biological resources into economic wealth and employment
opportunities. Innovative products and services that
draw on renewable resources bring greater efficiency
into industrial processes, check environmental degradation
and deliver a more bio-based economy.
Indian agriculture faces the formidable challenge of
having to produce more farm commodities for our growing
human and livestock population from diminishing per
capita arable land and water resources. Biotechnology
has the potential to overcome this challenge to ensure
the livelihood security of 110 million farming families
in our country.
The advancement of biotech as a successful industry
confronts many challenges related to research and development,
creation of investment capital, technology transfer
and technology absorption, patentability and intellectual
property, affordability in pricing, regulatory issues
and public confidence. Central to this are two key factors:
affordability and accessibility to the products of biotechnology.
Policies that foster a balance between sustaining innovation
and facilitating technology diffusion need to be put
in place.
There are several social concerns that need to be
addressed in order to propel the emergence of biotechnology
innovation in our country such as conserving bioresources
and ensuring safety of products and processes. Government
and industry have to play a dual role to advance the
benefits of modern biotechnology while at the same time
educate and protect the interests of the public. Wide
utilization of new technologies would require clear
demonstration of the new added value to all stakeholders.
The National Science and Technology Policy of the Government
and the Vision Statement on Biotechnology issued by
the Department of Biotechnology have directed notable
interventions in the public and private sectors to foster
life sciences and biotechnology. There has been substantial
progress in terms of support for R&D, human resource
generation and infrastructure development over the past
decade. With the introduction of the product patent
regime it is imperative to achieve higher levels of
innovation in order to be globally competitive. The
challenge now is to join the global biotech league.
This will require larger investments and an effective
functioning of the innovation pathway. Capturing new
opportunities and the potential economic, environmental,
health and social benefits will challenge government
policy, public awareness, educational, scientific, technological,
legal and institutional framework.
The issue of access to the products arising from biotechnology
research in both medicine and agriculture is of paramount
importance. Therefore, there should be adequate support
for public good research designed to reach the unreached
in terms of technology empowerment. Both "public
good" and "for profit" research should
become mutually reinforcing. Public institutions and
industry both have an important role in the process.
The National Biotechnology Development Strategy takes stock of what has been accomplished and provides a framework for the future within which strategies and specific actions to promote biotechnology can be taken. The policy framework is a result of wide consultation with stakeholders-scientists, educationists, regulators, representatives of society and others and reflects their consensus.It focuses on cross-cutting issues such as human resource development, academic and industry interface, infrastructure development, lab and manufacturing, promotion of industry and trade, biotechnology parks and incubators, regulatory mechanisms, public education and awareness building.This policy also aims to chalk out the path of progress in sectors such as agriculture and food biotechnology, industrial biotechnology, therapeutic and medical biotechnology, regenerative and genomic medicine, diagnostic biotechnology, bio-engineering, nano-biotechnology, bio-informatics and IT enabled biotechnology, clinical biotechnology, manufacturing & bio-processing, research services, bio-resources, environment and intellectual property & patent law.
This is the time for investment in frontier technologies
such as biotechnology. It is envisaged that clearly
thought-out strategies will provide direction and enable
action by various stakeholders to achieve the full potential
of this exciting field for the social and economic well
being of the nation.
Full
text of the policy
Results Framework Document
for
Department of Bio-Technology
Vision
The vision of the department is to create biotechnology tools and technologies that address
the problems of agriculture productivity, food production, nutrition security, health care and environmental sustainability by providing new and emerging products and services at
affordable prices, generate employment opportunities and make India globally competitive
in the emerging bio-economy.
Mission
The Department of Biotechnology aims at achieving its vision by facilitating emergence of a system that promotes excellence and sustains innovation through implementation of novel schemes/programmes and institutional mechanisms to:
- ensure availability of required numbers of world class scientists and professionals
relevant to R&D and technology development alongwith a well trained and skilled technical work force for industry.
- establish adequate infrastructure, biotechnology incubators and clusters.
- catalyze early stage innovation through investments and support services.
- engage public-private partnerships for development of products of social relevance for applications in agriculture, healthcare, environment and industry.
- provide a fiscal, regulatory and legal framework that encourages risk taking by investors.
Objectives
- Ensure availability of adequate human resource at all levels
- Engage public-private partnerships for development of products of social relevance
- Promote basic and translational research for development of products and processes of social relevance
- Establish of new centres of excellence and technology platforms
To view full text of the policy Click here
Future Outlook
Looking
at the future, India will go the innovation way. The
government funding in terms of providing finance, getting
into PPPs, their commitment in developing this sector
is encouraging and it is prepared to be a financier
and steer regulations. Globalization in biotech is largely
India-centric. In the future, India will be a part of
the global market and will be a part of the pie across
the value chain. There will be a lot of marketing alliances
where companies abroad can come and Indian companies
will play the role of contract sales organizations (CSOs).
It will not just be about business opportunities but
capability development that will expose India to actively
learn the expertise of the partner.
Based on the current trends and the
new progressive biotech policies, the forecast for 2015
is that the Indian biotech industry would have annual
revenues in excess of US $13 billion.
Useful Web Links
|
